# Using an Electronic Nose to Predict Gastrointestinal Consequences of Pelvic Radiotherapy

> **NCT02649491** · — · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 120 (estimated)

## Conditions studied

- Cancer
- Toxicity
- Malignancy

## Interventions

- **OTHER:** Cohort Observation

## Key facts

- **NCT ID:** NCT02649491
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2018-01
- **Final completion:** 2019-10
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2018-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02649491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02649491, "Using an Electronic Nose to Predict Gastrointestinal Consequences of Pelvic Radiotherapy". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02649491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*